PRELUDE CAPITAL MANAGEMENT, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$9,000
-92.7%
126
-93.2%
0.00%
-92.3%
Q3 2016$123,000
+39.8%
1,858
+18.0%
0.01%
+8.3%
Q2 2016$88,000
+63.0%
1,574
+31.2%
0.01%
+50.0%
Q4 2015$54,000
-20.6%
1,200
+9.1%
0.01%
-20.0%
Q2 2015$68,000
+54.5%
1,100
+57.1%
0.01%
+66.7%
Q1 2015$44,000
-44.3%
700
-50.0%
0.01%
-50.0%
Q4 2014$79,000
-63.8%
1,400
-81.8%
0.01%
-61.3%
Q3 2014$218,000
+373.9%
7,700
+470.8%
0.03%
+416.7%
Q2 2014$46,000
-31.3%
1,349
-37.2%
0.01%
-33.3%
Q1 2014$67,0002,1490.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders